The 5 Best Stock Funds for 9.9% Dividends and 10% Upside

Our Archive

Search completed

The Contrary Investing Report > NYSE:HQH

For those of you shaking your head at your portfolio’s low yield, you can actually 2X or 3X your portfolio’s yield and improve your upside potential to boot using this strategy. And it’s actually simpler than traditional stock picking.

Many income investors have mistakenly parked their capital in “safe” consumer staples like General Mills (GIS), Kimberly-Clark (KMB) and Procter & Gamble (PG) in search of yield and security. Their money was safe, all right: their cash went nowhere – straight sideways – for the last five years!

They’d have been better off “outsourcing” their dividend decisions to the great Mario Gabelli.… Read more

Read More

Forget the 2018 market drop—because it’s handed us a golden opportunity to grab some double-digit “bounce-back” gains in as 2019 rolls out.

I’ll tell you why I’m so excited about the year ahead in a moment. Then I’ll give you eight cheap funds set to arc higher as we move through 2019.

The kicker? Not only are these eight funds poised for big gains in the next 12 months, they throw off incredible dividend yields up to 12.6%, too!

Putting 2018 in Context

First, back to last year’s return, which came in at negative 6.1%, including dividends.

The first bit of good news here is that despite their decline, US stocks still led the rest of the world.… Read more

Read More

Today I want to show you a beaten-down sector that has a long history of crushing the market—and 4 funds that should be on your radar now.

These 4 funds are a great place to pocket dividends up to 10.9% (or $10,900 a year on a $100k investment) while you wait for the market to realize that it’s discounting their industry far too much.

I’m talking about 4 standout fund buys from the biotech sector.

Biotech has fallen over 10% from its 2018 high and is now down a bit more than the broader market. Just look at the iShares Nasdaq Biotechnology ETF (IBB) vs.…
Read more

Read More

There are 20 elite closed-end funds (CEFs) that have proven their toughness in the last 10 years (including through the Great Recession, the most brutal test of all) and have still handed investors market-beating returns.

And below we’re going to look at all 20 of them.

So if you’re looking for a proven dividend payer that will hold its own through today’s troubles—trade wars and rising interest rates, to name just two—these 20 funds are a great place to start.

The Toughest of the Tough

Some of these cash machines throw off dividends of 6.8% or more (and one I’ll tell you about in a moment pays a sky-high 12.4%!).…
Read more

Read More

I had an odd experience a couple weeks ago.

I met up with some money managers and financial advisors. They were discussing the same problem: how tough it is to beat the market.

Since I focus on closed-end funds, and since I know of many CEFs that have beaten the market thanks to smart managers (I showed you 16 whose average return has crushed the S&P 500 back in November), I found this discussion puzzling. I asked them what they thought about the CEFs that have beaten the market.

The responses were pretty much the same. “It won’t continue … they were lucky … they just beat the market for a short period … index funds will ultimately outperform.”

A Cult in the Making

The trend toward passive index investing is turning into a cult.…
Read more

Read More

Categories